Suzhou kunpeng biotechnology co., LTD., founded in February 2013, is a high-tech enterprise located in suzhou. The company takes "providing drugs, technologies and services for human disease control" as its mission and devotes itself to the r&d, production and sales of human drugs.In the field of diabetes treatment drugs, the company has established a product chain including recombinant human insulin, insulin glargine, insulin mendong, lilaru peptide and other drugs by using the unique platform of "protein fixed-point modification technology" and subversive process engineering technology development. At the same time, many new drugs such as new long-acting insulin and glp-1 analogues are also being actively promoted.The company has completed preliminary pre-clinical research in the field of osteoporosis Details>>
Graduation season | Youth is just right, "job"
Graduation season | Youth is just right, "job" is for you
[Good news] Kunpeng successfully bid......
Kunpeng Bio has actively participated in the auction of state-owned industrial land. As of September 19, 2019, it had successfully auctioned Kundi.com's "2019" Gongzai No. 35, the east side of Gucheng Road
Annual Meeting 丨 Building the future......
Kunpeng Biological Annual Meeting 2019 January 03, 2020 Kunpeng Bio's 2019 annual conference has quietly kicked off 2019 is a year worth remembering This year, every day of Kun Peng is changing and moving forward.
Epidemic prevention and control resumed ......
Epidemic prevention and control has entered a new stage, and the tide of resumption of work and production is approaching. In the more than half a month
Copyright? 2019 Copyright ? 2012 kunpeng biotechnology co., LTD. All rights reserved